The stem cell E3-ligase Lin-41 promotes liver cancer progression through inhibition of microRNA-mediated gene silencing
Journal
Journal of Pathology
Journal Volume
229
Journal Issue
3
Pages
486-496
Date Issued
2013
Author(s)
Abstract
Lin-41 is a stem cell-specific E3 ligase and a known target of the tumour suppressor microRNA (miRNA) let-7. Lin-41 was recently reported to mediate ubiquitylation and degradation of the miRNA pathway protein Ago2. We demonstrate that Lin-41 is over-expressed in hepatocellular carcinoma (HCC). Lin-41 over-expression correlates with high α-fetoprotein level, high tumour grade and high tumour stage and predicts early tumour recurrence. Lin-41 is a strong predictor of poor long-term survival for patients with HCC. Lin-41 knock-down by RNA interference in HCC cell lines Huh7 and Hep3B suppressed proliferation in vitro and reduced in vivo tumour growth in NOD/SCID mice. On the other hand, over-expression of Lin-41 in the HCC cell line SK-Hep1 enhanced tumourigenicity. Over-expression and knock-down of Lin-41 led to inverse changes in the levels of Ago1 and Ago2 proteins. Over-expression of Ago1 and Ago2 reduced in vivo tumour growth. Lin-41 over-expression suppressed let-7 activity in HCC cell lines and expression of Lin-41 enhanced the expression of let-7-regulated oncogenes c-Myc, Lin-28B, HMGA2 and type 1 insulin-like growth factor receptor (IGF1R). Expression of Lin-28B and c-Myc enhanced the expression of Lin-41. Chromatin immunoprecipitation and reporter assays revealed direct association of c-Myc with the Lin-41 promoter, resulting in transcriptional transactivation. Our results indicate that Lin-41 plays an important role in the growth of HCC by regulating RISC complex proteins Ago1 and Ago2 to inhibit miRNA-mediated gene silencing and promote the expression of oncogenic proteins. Lin-41 is also a strong prognostic factor for patients with HCC. Copyright ? 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Copyright ? 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
SDGs
Other Subjects
alpha fetoprotein; argonaute 1 protein; argonaute 2 protein; high mobility group A2 protein; Lin 41 ligase; microRNA; microRNA let 7; somatomedin C receptor; ubiquitin protein ligase E3; unclassified drug; adolescent; adult; aged; animal experiment; animal model; animal tissue; article; cancer cell culture; cancer grading; cancer growth; cancer inhibition; cancer recurrence; cancer staging; cancer stem cell; carcinogenicity; chromatin immunoprecipitation; controlled study; correlation analysis; enzyme activity; female; gene expression regulation; gene silencing; human; human cell; human tissue; liver cancer; liver carcinogenesis; liver cell carcinoma; long term survival; major clinical study; male; mitosis inhibition; mouse; nonhuman; oncogene; oncogene c myc; oncogene Lin 28B; priority journal; prognosis; promoter region; protein blood level; protein degradation; protein expression; regulatory mechanism; RNA interference; transactivation; ubiquitination; Adaptor Proteins, Signal Transducing; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Argonaute Proteins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Disease Progression; Eukaryotic Initiation Factors; Female; Gene Silencing; Humans; Liver Neoplasms; Male; Membrane Proteins; Mice; Mice, Inbred NOD; Mice, SCID; MicroRNAs; Middle Aged; Neoplastic Stem Cells; Young Adult
Type
journal article